Qube Research & Technologies (QRT)’s Harmony Biosciences HRMY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-352,637	Closed	-$9.88M	–	3741
2026 Q1	$9.88M	Buy	352,637 +314,520	+825%	+$10.3M	0.01%	1291
2025 Q4	$1.43M	Buy	+38,117	New	+$1.25M	﹤0.01%	2407
2025 Q3	–	Sell	-25,231	Closed	-$797K	–	3752
2025 Q2	$797K	Buy	+25,231	New	+$812K	﹤0.01%	2550
2024 Q3	–	Sell	-7,209	Closed	-$217K	–	3660
2024 Q2	$217K	Sell	7,209 -5,222	-42%	-$157K	﹤0.01%	2401
2024 Q1	$417K	Sell	12,431 -27,292	-69%	-$876K	﹤0.01%	2639
2023 Q4	$1.28M	Buy	39,723 +39,166	+7,032%	+$1.09M	﹤0.01%	1777
2023 Q3	$18.3K	Buy	+557	New	+$19.3K	﹤0.01%	3170
2023 Q1	–	Sell	-50,779	Closed	-$2.8M	–	2737
2022 Q4	$2.8M	Buy	+50,779	New	+$2.79M	0.02%	832
2022 Q2	–	Sell	-22,830	Closed	-$1.11M	–	2774
2022 Q1	$1.11M	Buy	+22,830	New	+$931K	0.01%	1118
2021 Q1	–	Sell	-13,072	Closed	-$473K	–	2134
2020 Q4	$473K	Buy	13,072 +6,465	+98%	+$261K	0.01%	1142
2020 Q3	$224K	Buy	+6,607	New	+$241K	﹤0.01%	1357

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HRMY Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 352,637 shares — an estimated $9.88M sold.

Qube Research & Technologies (QRT) first reported a position in HRMY in Q3 2020 and held it in 11 quarters. The position peaked at $9.88M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Qube Research & Technologies (QRT) reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 352,637 Harmony Biosciences shares in Q2 2026, an estimated $9.88M.
Qube Research & Technologies (QRT) first reported a position in Harmony Biosciences in Q3 2020 and held it in 11 quarters.
Qube Research & Technologies (QRT)'s Harmony Biosciences position peaked at $9.88M in Q1 2026.
327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.